# Natural Compounds and CYP3A4 — HER2CLIMB Considerations Many people use supplements alongside cancer treatment. Some of these compounds may affect liver enzymes and transporters, especially **CYP3A4**, which matters for drugs such as **tucatinib**. {% hint style="warning" %} This page is educational only. Do not start, stop, or time supplements around treatment without checking with your oncology team and pharmacist. {% endhint %} ### Why CYP3A4 matters here Within the HER2CLIMB regimen, the main CYP3A4 concern centres on **tucatinib**. * **Tucatinib** has meaningful CYP3A4 interaction relevance * **Capecitabine** is not primarily cleared through CYP3A4 * **Trastuzumab** is not handled through CYP3A4 metabolism That means supplement-related CYP3A4 questions in this regimen are usually about whether they may alter **tucatinib exposure**. ### How to use this page Use this page as a practical discussion guide. It does **not** prove that a given supplement will definitely raise or lower tucatinib levels in a real patient. In most cases, the evidence is still preclinical, mixed, or formulation-dependent. ### Curcumin **What it is** Curcumin is the main yellow polyphenol in turmeric. It is commonly used for anti-inflammatory and antioxidant support. **How it may affect CYP3A4** * preclinical studies suggest curcumin can inhibit CYP3A4 * some metabolite data suggest possible activation in some settings * the overall effect may depend on dose, formulation, and metabolism **Evidence in brief** * cell-based assays have shown strong CYP3A4 inhibition at micromolar concentrations * some studies suggest curcumin metabolites can increase CYP3A4 activity * human oncology interaction data remain limited **Points to discuss with the care team** * whether the person is using turmeric or a high-dose curcumin product * the exact formulation and dose * whether there are unexpected tucatinib side effects or tolerability changes **See also:** [Curcumin Pharmacokinetics & Metabolism](/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/pharmacokinetics-and-metabolism.md) ### EGCG **What it is** EGCG is the main catechin in green tea and in many green-tea extracts. **How it may affect CYP3A4** * EGCG can inhibit CYP3A4 in vitro * the effect appears concentration-dependent * repeated human dosing studies suggest the real-world effect may be modest or variable **Evidence in brief** * human liver microsome studies support CYP3A4 inhibition * animal data suggest pharmacokinetic interactions with some drugs * repeated human catechin dosing has often shown limited CYP change overall **Points to discuss with the care team** * daily green tea intake * use of high-dose EGCG extracts * whether there are changes in treatment tolerance that might reflect altered drug handling **See also:** [EGCG Pharmacokinetics & Metabolism](/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/pharmacokinetics-and-metabolism.md) ### Quercetin **What it is** Quercetin is a flavonoid found in many foods and in standalone antioxidant supplements. **How it may affect CYP3A4** * quercetin inhibits CYP3A4 in a concentration-dependent way * it may also inhibit P-glycoprotein * combined CYP3A4 and transporter inhibition could increase oral drug exposure **Evidence in brief** * in vitro data support CYP3A4 inhibition * animal work suggests increased exposure to some orally administered drugs * metabolite activity appears weaker than parent-compound activity **Points to discuss with the care team** * whether quercetin is being used as a single supplement or inside a blend * whether P-gp interaction relevance may matter as much as CYP3A4 * whether side effects could reflect increased tucatinib exposure ### Resveratrol **What it is** Resveratrol is a stilbene polyphenol found in grapes, berries, and some supplements. **How it may affect CYP3A4** * resveratrol can inhibit CYP3A4 in vitro * it has also been described as a mechanism-based inactivator * it may suppress inducible CYP3A4 expression through PXR-related pathways **Evidence in brief** * intestinal and liver models support CYP3A4 inhibition * some clinical data suggest higher exposure to drugs metabolised by CYP3A4 * the real effect depends on dose, product, and co-medications **Points to discuss with the care team** * whether resveratrol is being used directly or indirectly via related products * whether there is concern about higher tucatinib exposure * whether liver function and side effects need closer review **HER2-positive breast-cancer caution** * this is a separate caution from the CYP3A4 question * in **HER2-positive, ERα-positive breast cancer**, there is a specific **Δ16HER2 / resveratrol** concern * in a **Δ16HER2 transgenic breast-cancer model**, resveratrol accelerated tumour development rather than suppressing it * because **polydatin** is metabolised toward resveratrol, that caution should also be kept in mind when discussing polydatin * this signal is important, but it has **not** been confirmed in human oncology trials **See also:** [Should HER2+/ERα+ Patients Avoid Resveratrol or Polydatin?](/myhealingcommunity-docs/breast-cancer/her2-positive/should-her2+-era+-patients-avoid-resveratrol-or-polydatin.md) and [HER2+ Cancers](/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/her2+-cancers.md) ### Milk thistle / silymarin **What it is** Milk thistle is a herbal extract used mainly for liver support. Silymarin is its main active flavonolignan complex. **How it may affect CYP3A4** * preclinical work suggests CYP3A4 inhibition is possible * some studies show strong suppression in cell systems * human findings are mixed and may depend on dose and formulation **Evidence in brief** * liver-cell and microsomal studies support inhibition potential * some patient studies have shown little measurable CYP3A4 effect * real-world impact may vary with the extract used **Points to discuss with the care team** * the exact milk thistle product and standardisation * whether it is being used daily during tucatinib treatment * whether liver tests, tolerability, or exposure concerns justify review **See also:** [Pharmacokinetics, Bioavailability & Dosing](/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/pharmacokinetics-bioavailability-and-dosing.md) ### Bottom line The safest working assumption is that several commonly used natural compounds may have **some** CYP3A4 relevance, but the size and direction of the effect in a real patient are often uncertain. That is why the practical question is usually not just **"does this supplement affect CYP3A4?"** but **"does it affect it enough to matter for this treatment, at this dose, in this person?"** ### Related pages * [HER2CLIMB Guide](/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb/her2climb-guide.md) * [HER2CLIMB Resistance Mechanisms](/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb/her2climb-resistance-mechanisms.md) * [Tucatinib Clearance, Genetics, and Enzyme Inducers](/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb/tucatinib-clearance-genetics-and-enzyme-inducers.md) * [Liquid Biopsy for HER2-Positive Resistance](/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb/liquid-biopsy-for-her2-positive-resistance.md) ### References #### Curcumin Oral intake of curcumin markedly activated CYP3A4\ Curcuminoids inhibit multiple human cytochromes P450\ Possible inhibitory mechanism of Curcuma drugs on CYP3A4\ Curdione plays an important role in the inhibitory effect of Curcuma drugs\ Inhibition of human recombinant cytochrome P450s by Curcuma constituents\ #### EGCG Inhibitory Effects of Eight Green Tea Catechins on Cytochrome P450\ Inhibition by green tea catechins of metabolic activation\ Effects of Repeated Green Tea Catechin Administration on Human CYP Activity\ An Appraisal of Drug-Drug Interactions with Green Tea\ The Influence of EGCG on the Pharmacokinetics and Pharmacodynamics of Drugs\ #### Quercetin Role of CYP3A4 and P-gp inhibition by quercetin\ Inhibitory Effects of Quercetin and Its Main Methyl, Sulfate, and Glucuronide Metabolites\ Quercetin pretreatment increases the bioavailability of doxorubicin\ Interactions between CYP3A4 and Dietary Polyphenols\ Quercetin inhibits arachidonic acid metabolism by CYP enzymes\ #### Resveratrol Inhibition of cytochrome P450 3A by acetoxylated resveratrol derivatives\ Resveratrol suppresses the inducible expression of CYP3A4\ Resveratrol is a mechanism-based inactivator of CYP3A4\ Interactions of resveratrol and its metabolites with human CYP enzymes\ Trans-resveratrol, but not other natural stilbenes, inhibits CYP3A4\ #### Milk thistle/silymarin Milk Thistle, a Herbal Supplement, Decreases CYP3A4 Activity\ Milk thistle decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase\ The Effects of Milk Thistle on Human Cytochrome P450 Activity\

Would you like to ask Abbey about the information shared on this page? Would you like to contribute your experience, research or ideas to this page? Perhaps you want to point out something that needs changing?

Feedback Form

{% hint style="warning" %} This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use. {% endhint %} {% hint style="info" %} © 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text. {% endhint %} --- # Agent Instructions: Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter: ``` GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb/natural-compounds-and-cyp3a4-her2climb-considerations.md?ask= ``` The question should be specific, self-contained, and written in natural language. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.